Types of infusions for hemophilia A treatment: What patients and families need to know
Hemophilia A is a bleeding disorder caused by low levels of Factor VIII, a protein that helps blood clot properly. When Factor VIII is low, bleeding may last longer than normal and can sometimes occur inside the body—especially into joints or muscles. Many people manage hemophilia A by replacing missing Factor VIII with clotting factor concentrates given through an intravenous (IV) infusion. Other options such as non-factor therapies and gene therapies may also be part of care.
This guide focuses specifically on clotting factor replacement therapy given through IV infusion and explains how infusion plans vary depending on whether the goal is to stop or prevent bleeding. Optimal care for hemophilia A generally involves a team of different specialists working together to tackle diagnosis, treatment, and complication management, with attention to physical health, psychosocial well-being, and quality of life.
What is hemophilia A infusion treatment?
Clotting factor infusion treatment is one way to manage hemophilia A. During an infusion, Factor VIII concentrate is injected through a vein, temporarily raising factor levels so that the body can form blood clots more effectively.
The goals of infusion treatment are to stop bleeding, help prevent bleeding, protect joints, and support a healthy lifestyle. Your care team will recommend a plan based on your hemophilia severity, bleeding history, age, activity level, and preferences.
If factor levels are very low, bleeds may happen more often, especially in joints, muscles, or internal organs. Having a treatment plan and knowing when to contact the care team can help you respond quickly and prevent long-term complications.
Talk to your care team about the safety, complications, and side effects of Factor VIII replacement therapy.
Read more

Types of clotting factor infusions for adults and children with hemophilia A
Infusions are a key part of treatment for both children and adults living with hemophilia A. Learning self-infusion can make treatment easier to fit into your everyday routine and may support independence and flexibility at home or while traveling.
Infusion options at a glance
On-demand (episodic) infusions
On-demand infusions are given to stop bleeding episodes. This approach treats bleeds as they occur rather than trying to prevent them.
Prophylactic (preventive) infusions
Prophylactic infusions involve regular factor replacement to prevent bleeds. Instead of waiting for bleeds to happen, you maintain protective factor levels in your bloodstream through scheduled infusions. This approach can help stop most spontaneous bleeds and help preserve joint health over time.
Emerging therapies
The treatment landscape of hemophilia A care continues to evolve, including extended half-life factor products, which stay in the body longer and reduce how often you need infusions, and non-factor therapies (treatments that don't replace actor VIII) that work differently to help blood clot. Some of these new options can be given as a shot under the skin (subcutaneous) rather than being infused into a vein.
Infusions given to children with hemophilia
Children with hemophilia may start infusion treatment as early as infancy or toddlerhood, depending on the severity of their condition and their factor levels. The main goals of starting treatment early are preventing bleeds before they occur, managing sudden bleeds, protecting joint health, building familiarity and comfort with treatment, and supporting normal development.
Because finding a vein in young children can be difficult, your care team might recommend a central venous access device (often called a port) to make infusions easier and less stressful.
Learning self-infusion
Self-infusion means learning to administer factor treatment at home, after proper training, giving you faster access to treatment when needed. Potential benefits may include quicker response during bleeds and more independence and flexibility in your daily life.
It is important that you recognize bleeds as they happen and keep an accurate record of the date and site of the bleeding, as well as the product you used to treat it, including dosage and lot number. You can keep this record on paper or electronically, and it will help you and your care team keep track of your factor levels, as the severity of bleeding episodes in hemophilia is generally correlated with how low your clotting factor is.
Learning to infuse requires proper training from your healthcare team. Building confidence in infusion skills may help you treat bleeds early, as advised by your care team, and protect your joints and health in the long run.
Emergency care for patients with hemophilia A
Knowing how to handle urgent situations is important for people with hemophilia A, as delays in getting appropriate care can lead to serious complications.
Being prepared for emergencies includes having a clear plan, knowing which symptoms need urgent care (such as head injury), and being able to self-advocate for appropriate care when needed.
Signs you need urgent medical help include suspected bleeding into a joint or muscle, significant injury to the head, neck, mouth or eyes, new or unusual headache, particularly after an injury, severe pain or swelling, open wounds that may need stitches, suspected internal bleeding after trauma, and heavy or persistent bleeding.
Patients or caregivers are encouraged to carry a treatment plan card or dosing guidance from their hemophilia treatment center (HTC). During any medical emergency, follow your care team’s plan and seek urgent care when symptoms are serious.
Having emergency supplies at home for emergencies and knowing how to access care while traveling can help you feel more prepared. Ask your care team what they recommend for your situation.
Talking with your care team
Open, ongoing communication with your healthcare providers is the foundation of successful hemophilia A management. Patients and caregivers are core members of the comprehensive care team and partners in making decisions together.
Regular check-ins allow your care team to monitor your health status (bleeding patterns, joint health), assess how your current treatment is working, and make adjustments if needed. Many people are seen at least once a year, while those with mild or moderate hemophilia may need less frequent visits based on their symptoms, bleeding history, and individual needs.
Learn more about the severity levels of hemophilia.
Read more

Find your CoRe Manager and connect today!
Sanofi Hemophilia Community Relations and Education (CoRe) Managers offer education to
people living with hemophilia and their families. CoRe Managers provide information about
living with hemophilia and treatment options. Use our handy CoRe Locator to find the CoRe
team member nearest you.
ALTUVIIIO® [antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtl] is an injectable medicine that is used to control and reduce the number of bleeding episodes in people with hemophilia A (congenital Factor VIII deficiency).
Your healthcare provider may give you ALTUVIIIO when you have surgery.
What is the most important information I need to know about ALTUVIIIO?
Do not attempt to give yourself an injection unless you have been taught how by your healthcare provider or hemophilia center. You must carefully follow your healthcare provider’s instructions regarding the dose and schedule for injecting ALTUVIIIO so that your treatment will work best for you.
Who should not use ALTUVIIIO?
You should not use ALTUVIIIO if you have had an allergic reaction to it in the past.
What should I tell my healthcare provider before using ALTUVIIIO?
Tell your healthcare provider if you have had any medical problems, take any medications, including prescription and non-prescription medicines, supplements, or herbal medicines, are breastfeeding, or are pregnant or planning to become pregnant.
What are the possible side effects of ALTUVIIIO?
You can have an allergic reaction to ALTUVIIIO. Call your healthcare provider or emergency department right away if you have any of the following symptoms: difficulty breathing, chest tightness, swelling of the face, rash, or hives.
Your body can also make antibodies called “inhibitors” against ALTUVIIIO. This can stop ALTUVIIIO from working properly. Your healthcare provider may give you blood tests to check for inhibitors.
The common side effects of ALTUVIIIO are headache and joint pain.
These are not the only possible side effects of ALTUVIIIO. Tell your healthcare provider about any side effect that bothers you or does not go away.
Please see full Prescribing Information.
Learn more about Sanofi’s commitment to fighting counterfeit drugs.
![ALTUVIIIO® [Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl] logo](/.imaging/default/dam/Marketing/AltuviiioUS/altuviiio.webp/jcr:content.webp)